SEC Form D · filed February 6, 2023
Niche Biopharmaceuticals LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Daniel Saccani · Reno, NVDirectorDayton Reardan · Shorewood, MNExec · Director · PromoterPatrick M. Schlievert · Iowa City, IADirectorPaul Brennan · Oxford, United KingdomDirectorRobert M. Klem · San Diego, CADirectorJacob Yormak · New York, NYExec · Director · PromoterDarin P. Anderson · Billings, MTDirectorGregory J. Casals · Boulder, CODirectorDonald P. Jensen · Billings, MTDirectorBin T. He · Cranbury, NJExec · Director · PromoterJeff D. Iverson · New York, NYDirectorSydney Barker · Atlanta, GADirectorMichelle Oppelt · Atlanta, GADirectorRobert M. Klem · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗